News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Argos Therapeutics, Inc. and Therakos, Inc. Enter Exclusive Agreement for Regulatory T Cell Technology



11/16/2007 9:55:42 AM

DURHAM, N.C.--(BUSINESS WIRE)--Argos Therapeutics announced today that it has granted Therakos, Inc., a Johnson & Johnson company, an exclusive license for the research and development of novel treatments based on regulatory T cell technology developed by Argos. Terms of the agreement were not disclosed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES